1.
Radiother Oncol
; 73(3): 321-4, 2004 Dec.
Article
in English
| MEDLINE
| ID: mdl-15588877
ABSTRACT
In a phase II study, we assessed the toxicity and efficacy of daily low-dose cisplatin (6 mg/m2) and weekly vinorelbine (15 mg/m2) with concurrent thoracic irradiation (60 Gy) for locally advanced non-metastasized non-small-cell lung cancer. The overall response rate was 65%, complete response 12% and the median overall survival was 64 weeks.